Pfizer Near Potential $7.3 Billion Metsera Takeover, FT Says (2)

Pfizer Inc. is closing in on a potential $7.3 billion takeover of obesity startup Metsera Inc., the Financial Times reported, as the drug giant looks to bolster its pipeline after the recent failure of its closely-watched weight-loss pill.

The deal could be announced as early as Monday, the FT reported, citing unidentified people familiar with the matter.

Pfizer will pay Metsera $47.50 in cash per share, and a further $22.50 if certain performance milestones are met, the people told the FT. The agreement represents a premium to Metsera’s Friday share price close of just over $33 in New ...